BREAKING: Bullish Rebound Pares Market's Weekly Losses Shares of Crinetics Pharmaceuticals (CRNX) surged Friday after the Food and Drug Administration approved the company's acromegaly drug, Palsonify. Acromegaly is a rare condition in which the pituitary gland produces too much growth hormone. This causes some bones, organs and other tissues to grow bigger. The late wrestler and actor Andre Rene Roussimoff — widely known as "Andre the Giant" — suffered from acromegaly. Palsonify will cost $290,000 a year, ...